Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES

Professor and Chief of Pediatric Neurology
Le Bonheur Chair in Pediatric Neurology
University of Tennessee Health Sciences Center
Director, Le Bonheur Comprehensive Epilepsy Program & Neuroscience Institute
Le Bonheur Children's Hospital
Memphis, Tennessee

Disclosures

Disclosure: James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES, has the following relevant financial relationships:
Grants for clinical research from: Aucta; Avexis; Envision; Epiwatch; Marinus; Neurecrine; Neurelis; Neuro Event Labs; NeuroPace; SKL SI; Stoke; UCB, Xenon
Advisor or consultant for: BioMarin; Eisai; Marinus; Neurelis; Neuro Event Labs; Supernus
Speaker or member of speakers bureau for: Aquestive; BioMarin; Eisai; Greenwich; Neurelis; LivaNova; SKL SI; Supernus; UCB; Zogenix

Christianne N. Heck, MD, MMM, FAES

Professor of Clinical Neurology
Keck School of Medicine of USC
Los Angeles, California

Disclosures

Disclosure: Christianne N. Heck, MD, MMM, FAES, has the following relevant financial relationships:
Grants for clinical research from: Neuropace

Lawrence J. Hirsch, MD

Professor of Neurology
Chief, Division of Epilepsy and EEG
Co-Director, Comprehensive Epilepsy Center
Yale University
New Haven, Connecticut

Disclosures

Disclosure: Lawrence J. Hirsch, MD, has the following relevant financial relationships:
Advisor or consultant for: Accure; Aquestive; Ceribell; Eisai; Marinus; Medtronic; Neurelis; Neuropace; UCB
Speaker or member of speakers bureau for: Neuropace; Natus; UCB

Editors

Christina T. Loguidice, BA

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Christina T. Loguidice, BA, has disclosed no relevant financial relationships.

Ruwaida Vakil, MSc

Medical Writer, Medscape, LLC

Disclosures

Disclosure: Ruwaida Vakil, MSc, has disclosed no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME / CE

Clinical Recommendations in Drug-Resistant Epilepsy: Approaches to Neuromodulation Across the Age Spectrum

Authors: James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES; Christianne N. Heck, MD, MMM, FAES; Lawrence J. Hirsch, MD
CME / CE Released: 1/28/2022
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 1/28/2023, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This activity is intended for epileptologists, neurologists, neurosurgeons, pediatricians, nurses, physician assistants, and pharmacists.

The goal of this activity is to increase awareness of drug-resistant epilepsy (DRE), the differential impact of uncontrolled seizures across the lifespan of patients, and the role of neuromodulation in reducing seizure burden in patients with DRE.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Factors involved in the identification of patients with DRE who are candidates for neuromodulation
- Factors to communicate between providers when patient care transitions from pediatric to adult management
- Nonseizure consequences associated with poorly controlled seizures

Disclosures

Faculty

James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES

Professor and Chief of Pediatric Neurology
Le Bonheur Chair in Pediatric Neurology
University of Tennessee Health Sciences Center
Director, Le Bonheur Comprehensive Epilepsy Program & Neuroscience Institute
Le Bonheur Children's Hospital
Memphis, Tennessee

Disclosures

Disclosure: James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES, has the following relevant financial relationships:
Grants for clinical research from: Aucta; Avexis; Envision; Epiwatch; Marinus; Neurecrine; Neurelis; Neuro Event Labs; NeuroPace; SKL SI; Stoke; UCB, Xenon
Advisor or consultant for: BioMarin; Eisai; Marinus; Neurelis; Neuro Event Labs; Supernus
Speaker or member of speakers bureau for: Aquestive; BioMarin; Eisai; Greenwich; Neurelis; LivaNova; SKL SI; Supernus; UCB; Zogenix

Christianne N. Heck, MD, MMM, FAES

Professor of Clinical Neurology
Keck School of Medicine of USC
Los Angeles, California

Disclosures

Disclosure: Christianne N. Heck, MD, MMM, FAES, has the following relevant financial relationships:
Grants for clinical research from: Neuropace

Lawrence J. Hirsch, MD

Professor of Neurology
Chief, Division of Epilepsy and EEG
Co-Director, Comprehensive Epilepsy Center
Yale University
New Haven, Connecticut

Disclosures

Disclosure: Lawrence J. Hirsch, MD, has the following relevant financial relationships:
Advisor or consultant for: Accure; Aquestive; Ceribell; Eisai; Marinus; Medtronic; Neurelis; Neuropace; UCB
Speaker or member of speakers bureau for: Neuropace; Natus; UCB

Editors

Christina T. Loguidice, BA

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Christina T. Loguidice, BA, has disclosed no relevant financial relationships.

Ruwaida Vakil, MSc

Medical Writer, Medscape, LLC

Disclosures

Disclosure: Ruwaida Vakil, MSc, has disclosed no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For Nurses

Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Neurology & Neurosurgery

CME / CE

Clinical Recommendations in Drug-Resistant Epilepsy: Approaches to Neuromodulation Across the Age Spectrum

Authors: James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES; Christianne N. Heck, MD, MMM, FAES; Lawrence J. Hirsch, MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / CE Released: 1/28/2022

Valid for credit through: 1/28/2023, 11:59 PM EST

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Early Intervention in Drug-Resistant Epilepsy in Pediatric Patients

Understand available treatment options, including neuromodulation, for pediatric patients with drug-resistant epilepsy.
James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES

Understanding Neuromodulation in Adult Patients With DRE

Explore the pros and cons of various neuromodulation approaches for adult patients with drug-resistant epilepsy.
Christianne N. Heck, MD, MMM, FAES

Life With DRE: More Than Just Seizure Burden

Understand the consequences of poorly controlled seizures, including impact on body systems beyond the brain.
Lawrence J. Hirsch, MD

Page 1 of 4

Early Intervention in Drug-Resistant Epilepsy in Pediatric Patients

CME / CE Information

Print
Like Tweet

References

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES

Christianne N. Heck, MD, MMM, FAES

Lawrence J. Hirsch, MD

Editors

Christina T. Loguidice, BA

Ruwaida Vakil, MSc

Compliance Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

CME / CE

Clinical Recommendations in Drug-Resistant Epilepsy: Approaches to Neuromodulation Across the Age Spectrum

Target Audience and Goal Statement

Disclosures

Faculty

James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES

Christianne N. Heck, MD, MMM, FAES

Lawrence J. Hirsch, MD

Editors

Christina T. Loguidice, BA

Ruwaida Vakil, MSc

Compliance Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

Clinical Recommendations in Drug-Resistant Epilepsy: Approaches to Neuromodulation Across the Age Spectrum

Contents of This CME Activity

Early Intervention in Drug-Resistant Epilepsy in Pediatric Patients

Understanding Neuromodulation in Adult Patients With DRE

Life With DRE: More Than Just Seizure Burden